Literature DB >> 25903567

Changes in MMP-9 and TIMP-1 Concentrations in Cerebrospinal Fluid after 1 Week of Treatment of Childhood Bacterial Meningitis.

Irmeli Roine1, Tuula Pelkonen2, Anneli Lauhio3, Maija Lappalainen4, Manuel Leite Cruzeiro5, Luis Bernardino5, Taina Tervahartiala6, Timo Sorsa7, Heikki Peltola8.   

Abstract

We explored the changes of the initially highly upgraded cerebrospinal fluid matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of MMP 1 (TIMP-1) response during recovery of childhood bacterial meningitis and their association with outcome. The sizes of these changes varied substantially, but a steeper decrease in the MMP-9 and an increase of the TIMP-1 concentrations augured a better outcome.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25903567      PMCID： PMC4473225          DOI： 10.1128/JCM.00714-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

2.  Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.

Authors:  R L P Lindberg; T Sorsa; T Tervahartiala; F Hoffmann; L Mellanen; L Kappos; U B Schaad; S L Leib; D Leppert
Journal:  Neuropathol Appl Neurobiol       Date:  2006-06       Impact factor: 8.090

3.  Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis.

Authors:  Irmeli Roine; Tuula Pelkonen; Luis Bernardino; Anneli Lauhio; Taina Tervahartiala; Maija Lappalainen; Matti Kataja; Anne Pitkäranta; Timo Sorsa; Heikki Peltola
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

Review 4.  Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.

Authors:  D Leppert; R L Lindberg; L Kappos; S L Leib
Journal:  Brain Res Brain Res Rev       Date:  2001-10

5.  Slow initial β-lactam infusion and oral paracetamol to treat childhood bacterial meningitis: a randomised, controlled trial.

Authors:  Tuula Pelkonen; Irmeli Roine; Manuel Leite Cruzeiro; Anne Pitkäranta; Matti Kataja; Heikki Peltola
Journal:  Lancet Infect Dis       Date:  2011-05-05       Impact factor: 25.071

6.  Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.

Authors:  D Leppert; S L Leib; C Grygar; K M Miller; U B Schaad; G A Holländer
Journal:  Clin Infect Dis       Date:  2000-07-14       Impact factor: 9.079

7.  Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial.

Authors:  Heikki Peltola; Irmeli Roine; Josefina Fernández; Inés Zavala; Silvia González Ayala; Antonio González Mata; Antonio Arbo; Rosa Bologna; Greta Miño; José Goyo; Eduardo López; Solange Dourado de Andrade; Seppo Sarna
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

8.  Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.

Authors:  Fabian D Liechti; Denis Grandgirard; David Leppert; Stephen L Leib
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

9.  Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.

Authors:  Hung-Chin Tsai; Sheng-Fu Liu; Kuan-Sheng Wu; Yung-Ching Liu; Min-Hon Shi; Eng-Rin Chen; Chuan-Min Yen; Susan Shin-Jung Lee; Yen-Lin Huang; Yao-Shen Chen
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092
  9 in total
  10 in total

1.  Increased MMP-9 levels with strain-dependent stress resilience and tunnel handling in mice.

Authors:  Kate Kennedy-Wood; Christi Anne S Ng; Seham Alaiyed; Patricia L Foley; Katherine Conant
Journal:  Behav Brain Res       Date:  2021-04-06       Impact factor: 3.352

2.  Predicting Outcome of Childhood Bacterial Meningitis With a Single Measurement of C-Reactive Protein.

Authors:  Heikki Peltola; Tuula Pelkonen; Irmeli Roine; Manuel Leite Cruzeiro; Luis Bernardino
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

3.  Matrix metalloproteinase-9 activity and a downregulated Hedgehog pathway impair blood-brain barrier function in an in vitro model of CNS tuberculosis.

Authors:  Sara Brilha; Catherine W M Ong; Babette Weksler; Nacho Romero; Pierre-Olivier Couraud; Jon S Friedland
Journal:  Sci Rep       Date:  2017-11-22       Impact factor: 4.379

Review 4.  Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis.

Authors:  Naveed Sabir; Tariq Hussain; Mazhar Hussain Mangi; Deming Zhao; Xiangmei Zhou
Journal:  Cell Prolif       Date:  2019-06-14       Impact factor: 6.831

Review 5.  MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.

Authors:  Lukas Muri; David Leppert; Denis Grandgirard; Stephen L Leib
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

6.  CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With Streptococcus pneumoniae Meningitis.

Authors:  Emma C Wall; Philip Brownridge; Gavin Laing; Vanessa S Terra; Veronica Mlozowa; Brigitte Denis; Mulinda Nyirenda; Theresa Allain; Elisa Ramos-Sevillano; Enitan Carrol; Andrea Collins; Stephen B Gordon; David G Lalloo; Brendan Wren; Robert Beynon; Robert S Heyderman; Jeremy S Brown
Journal:  Front Cell Infect Microbiol       Date:  2020-12-11       Impact factor: 5.293

Review 7.  Infections in the Developing Brain: The Role of the Neuro-Immune Axis.

Authors:  John Kim; Clara Erice; Ursula K Rohlwink; Elizabeth W Tucker
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

8.  Expression of MMP-2 and TIMP-1 in cerebrospinal fluid and the correlation with dynamic changes of serum PCT in neonatal purulent meningitis.

Authors:  Huilan Chen; Fei Wu; Rong Fu; Xiangchun Feng
Journal:  Exp Ther Med       Date:  2017-11-22       Impact factor: 2.447

9.  The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.

Authors:  Okko Savonius; Irmeli Roine; Saeed Alassiri; Taina Tervahartiala; Otto Helve; Josefina Fernández; Heikki Peltola; Timo Sorsa; Tuula Pelkonen
Journal:  Mediators Inflamm       Date:  2019-11-03       Impact factor: 4.711

10.  Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid.

Authors:  Annelies Müller; Anke Salmen; Suzanne Aebi; Linda de Gouveia; Anne von Gottberg; Lucy J Hathaway
Journal:  BMC Microbiol       Date:  2020-01-20       Impact factor: 3.605
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.